# RSV vaccines slash infections: data show jabs’ staggering success against dangerous virus

> **Open Intelligence Dossier** · First detected: 2026-11-16 20:40 UTC · Category: Health

## Executive Summary
New data from multiple studies show RSV vaccines sharply reducing infections and hospitalizations in older adults and infants.

## Intelligence Brief
Coverage from McKnight&#039;s Long-Term Care News reports that a vaccine offers strong protection against RSV in adults over 50, according to a study published on November 12, 2026. Medical Daily reports that Moderna&#039;s RSV shot was 82 percent effective against hospitalization in veterans aged 50 and older, while noting that infection protection fell with age. Bioengineer.org reports that marketed RSV vaccines prove cost-effective for older adults but remain inconclusive for infants. IFLScience reports that hospitalizations for babies with RSV are plummeting thanks to immunization programs. Nature frames the trend broadly, stating that RSV vaccines slash infections with data showing jabs&#039; staggering success against the dangerous virus. The coverage emphasizes real-world effectiveness across age groups and settings, drawing on studies involving veterans, older adults, and infant immunization programs. RSV is a respiratory virus that can cause severe lower respiratory tract disease, particularly in older adults and young children, and hospitalization data is a key measure of vaccine impact. The coverage does not yet specify which vaccine products were evaluated in each study, the size of the study populations, or the exact duration of follow-up. Readers should watch for peer-reviewed publication of the veteran study, further cost-effectiveness analyses for infant programs, and any updates on duration of protection across age groups.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| McKnight's Long-Term Care News | Vaccine offers strong protection against RSV in adults over 50, study finds | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSi0xclM3cUh1Z3ZiSHhseFZ0aEt1TzRmajJHeGRmZHVMajdjWDFMMnlfR3Z4elRIbWNNYXFOUjdjc1ZPcGZ4TDM2MkZqZFFHZ1NudThBZDJObU02Yk1DQlQ0TUx2bkpLaHQzRk9tMFZJUkJWWXlLa1NTUTZjcjJfWG9laUhTalYtU3ZYTXQ1WnZIeEdWUE1PUDl3aklmSnhsRU5pV2tVcHFQdw?oc=5) |
| Medical Daily | Moderna RSV Shot 82% Effective Against Hospitalization in Veterans 50 and Older, but Infection Protection Fell With Age | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxON2FjUV9JU3dsZkY4ZnJKZVp3dXBTeDhGTDN3Zkk0eUV5R0MwbHlCWUl0WDZieWNtS0tMRng1MXVTVEljQ0t3TU11ZjlleFVmNmNMd3VzQ3hjOVpYZ0M2M0hRcGQ5Yi15U18yZF9UUEplczZTVGtsdVRjSFJ1UVJPUEhGbmJKVXFOeENIVGJpdWxWcjdoa0U1QTNETGFfUl9E?oc=5) |
| Bioengineer.org | Marketed RSV Vaccines Prove Cost-Effective for Older Adults but Inconclusive for Infants | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxPQjZFZkpWRzRmOFNjRl9WZVFRQWZPQUt0OE5ETVVkR2RyZTJvaUxkRkVDanNleG1RY0VsRktvb1JOV0xwdlFQQlB4X0JzQVRkOWtRSXp0LUhtX1FtZUlUbHV2TG1YeUpXYl9BdHBqTm9KaFZVTDd2TEd5RWlYUjE4WFZOWEpuWmt5MlNnYVhJVDhXeFRrZ3oxZENrQW9lUHg4TmhYUmV6Unh4dy1XMjZ2RlNaQQ?oc=5) |
| IFLScience | Thanks To Immunization Programs, Hospitalizations For Babies With RSV Are Plummeting | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxNNFc1ZndMQmdQVWxUQ01NVUM0YmVoQjY1WTdKT2RlT3ByMGF0ZlhlOU5HNU44aUpUdHVrS0pzX2NSa2hkT0hZX3duUHg2V0FXV0QxNnBJVnNkVjR4bl8weGhBeW1YOGd4UXlXOGFfZEFNa25JbjNEVUxiVzhKWkZrSUdFa1JzOERPZURIX0c5VUFKN2NlcmRXTnUzZkZ3YTVQYjRhSFdiY2RIeHdCa2F5T05ya3lraGc?oc=5) |
| Nature | RSV vaccines slash infections: data show jabs’ staggering success against dangerous virus | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0QzJKWnp0WFVTVEpkOGV1TkgzNGtaT0ZEUUplYjlCUFJSa0owOXBzX0pJcEhwY3N5RTh4ZEIyTWc0Y1lSZ1NocFVKNC1Dd1dldkN6eHJIb083eFBKR0xZ?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-11-16/rsv-vaccines-slash-infections-data-show-jabs-staggering-success-against*
